2025 BioInfect Conference

2025 BioInfect Conference

The Spine, Liverpool
Wednesday 5th February 2025

Event Logo

About

Antimicrobial resistance (AMR) is one of the top global public health and development threats. According to a 2022 article published in the Lancet, it is estimated that bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths.
 
Antimicrobial resistance: a growing issue
 
The misuse and overuse of antimicrobials in humans, animals and plants are the main drivers in the development of drug-resistant pathogens.
 
Without effective tools for the prevention and adequate treatment of drug-resistant infections and improved access to existing and new quality-assured antimicrobials, the number of people for whom treatment is failing or who die of infections will increase. Medical procedures, such as routine surgery (including caesarean sections or hip replacements), cancer chemotherapy, and organ transplantation, will become more risky.
 
Why attend BioInfect?
 
The agenda at BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed, including working towards an integrated, unifying approach that aims to achieve optimal and sustainable health outcomes; antimicrobial stewardship; increased investment and innovation in new treatments at all stages of the drug development pipeline and ensuring ROI in the development of new antimicrobials; and the use of strategic information to inform the AMR response.


If you have any questions about the conference please contact Matt Daly: matt.daly@bionow.co.uk

Key Information

Wednesday 5th February 2025 - Registration open!

Venue: The Spine, 2 Paddington, Liverpool L7 3FA

Exhibition now fully booked

Last few delegate places remaining - book now!

Keynote Speakers

Speaker image Erin Duffy

Erin Duffy
Chief of Research & Development , CARB-X

Speaker image Lloyd Payne

Lloyd Payne
Drug Discovery Executive, Kineticos Life Sciences

Speaker image Jef Grainger

Jef Grainger
Associate Director, Research Strategy and Programmes, Biotechnology and Biological Sciences Research Council

  • 08:30 Coffee and Registration

  • 09:00 Conference Welcome

    Simon Reid, Cluster & Inward Investment Director, Invest Liverpool City Region

  • 09:10 Keynote

    Jef Grainger, Associate Director, Research Strategy and Programmes, BBSRC

  • 09:30 State of the Possible Panel

    Chair: Becky Jones-Phillips, Director of Enterprise and Innovation, Liverpool School of Tropical Medicine

    Colin Brown, Deputy Director of Clinical & Emerging Infections at UK Health Security Agency

    Jonathan O’Halloran, CEO, QuantuMDx

    Peter Jackson, CEO, Infex Therapeutics

    Seamus Coyle, Consultant in Palliative Medicine, The Clatterbridge Cancer Centre NHS Foundation Trust

    Jane Freeman, Co-Deputy Theme Lead for AMRI, NIHR Leeds Biomedical Research Centre

  • 10:30 Coffee, Networking & Exhibition

  • 11:00 Keynote

    Erin Duffy, Chief of Research and Development, CARB-X

  • 11:20 iiCON – UKRI Fund Pilots Projects

    UKRI Fund Pilot Projects giving 7 minute presentations on their progress. 

    Farhad Ahmed, Head of Strategic Partnerships, LYVA Labs

    Charlotte Hemingway, Post Doctoral Research Associate, Liverpool School of Tropical Medicine

    Martin Scurr, Chief Scientific Officer, Immunoserv

    Catrin Moore, Reader in Global Health and Infectious Diseases, City St George's University of London

    Ruoxiao Xie, Lecturer of Bioengineering, University of Liverpool

    Craig Williams, Co-Founder, CCI Photonics

    Jon Austyn, Chief Scientific Officer, Iuvantium

  • 12:20 Lunch, Networking & Exhibition

  • 13:20 Poster Competition Results

    Chair: Pia Thommes, Expert Biologist Infectious Diseases

  • 13:35 Keynote

    Lloyd Payne, Drug Discovery Executive, Kineticos Life Sciences

  • 13:55 Keeping PACE with AMR: one year on - early-stage projects and enabling collaborations

    Beverley Isherwood, PACE Director & Strategy Leader – Infectious Diseases

  • 14:15 Hot Topics - What's in the pipeline

    Chair: Neil Murray, CEO, ReNewVax

    Carrie Ambler, CSO & Founder, LightOx

    Michael Murray, Executive Chairman and CEO, MetalloBio

    Daniel Walker, CSO & Co-Founder, GLOX Therapeutics

  • 15:15 Coffee, Networking and Exhibition

  • 15:45 Funding and Investment in AMR - How the North can take the lead

    Chair: Kate Hickinson, Partner, Appleyard Lees

    Janet Hemingway, Founding Director, iiCON

    Lloyd Payne, Drug Discovery Executive, Kineticos Life Sciences

    Phil Packer, Innovation Lead AMR and Vaccines, SRO for PACE, Innovate UK

    Ian Smith, Head of Investor Partnerships, CPI Enterprises

  • 16:45 Increasing the Engagement of Young People with the issue of Antimicrobial Resistance (AMR)

    Dr John Dyer and Students, Liverpool Life Sciences UTC

  • 17:00 Conference Close

Sponsors and Partners

Gold Exhibitors

                                                           

 

                                                              

         

Registration

Registration will open shortly. For any further queries please contact info@bionow.co.uk

Venue

The Spine is located in Paddington Village at the heart of the Knowledge Quarter in Liverpool’s City Centre, with Liverpool Lime Street station a 19-minute walk away

Travel

Nearest train station: Liverpool Lime Street – 19 minute walk – £5-6 taxi

  • 35 minutes from Manchester
  • 1 hour 20 minutes from Leeds
  • 3 hours 30 minutes from Glasgow
  • 2 hours from London
  • 1 hour 40 minutes from Birmingham

Parking

From M6 on to M57, M62 or M58

Motorway connections put the majority of UK cities within a four-hour drive time.

  • 45 minutes from Manchester and Chester
  • 2 hours from Birmingham
  • 3 hours 40 minutes from Glasgow
  • 4 hours from London

Car parking near Spaces at The Spine:

Paddington Village Multi-Storey
Standard day tariff: £12.00
Address: Elm Grove, Grove St, Smithdown Lane, Liverpool L7 3FA